Invention Application
![METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CERTAIN HEMATOLOGIC DISORDERS](/docs/US/2017-05-04/US20170119745A1/abs.jpg.600x600.jpg)
- Patent Title: METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CERTAIN HEMATOLOGIC DISORDERS
-
Application No.: US15173506Application Date: 2016-06-03
-
Publication No.: US20170119745A1Publication Date: 2017-05-04
- Inventor: Daniel C. Adelman , Jeffrey A. Silverman , Glenn Michelson , Caroline Dame Scatena
- Applicant: Sunesis Pharmaceuticals, Inc.
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; A61K31/7068
![METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CERTAIN HEMATOLOGIC DISORDERS](/abs-image/US/2017/05/04/US20170119745A1/abs.jpg.150x150.jpg)
Abstract:
Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of SNS-595. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. In certain embodiments, the method of treatment comprise administering SNS-595 in combination with Ara-C. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods are also disclosed.
Information query
IPC分类:
